This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Nexalin Technology’s 8K filing here.
Nexalin Technology Company Profile
Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia.
Featured Stories
- Five stocks we like better than Nexalin Technology
- What is the Nikkei 225 index?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- High Flyers: 3 Natural Gas Stocks for March 2022
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Insider Trades May Not Tell You What You Think
- Top Nuclear Stocks Thriving on Soaring Energy Demand
